SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Arquivos De Gastroenterologia
Isabella de Souza CunhaJuliane Stall

Abstract

Patients with inflammatory bowel disease (IBD) vaccinated for hepatitis B have a low success rate in achieving protective antibody levels. The main factors suggested for this are IBD itself and the use of immunosuppressive drugs. To evaluate the concentration of anti-HBs antibodies and to verify factors associated with the effectiveness of hepatitis B vaccination in patients with IBD. This is a prospective, consecutive, observational, descriptive and analytical, non-randomized, qualitative study that evaluated the levels of anti-HBs antibodies in IBD patients at the Interdisciplinary Inflammatory Bowel Disease Clinic of the Family and Community Health Unit of UNIVALI - Itajaí, Santa Catarina. Thirty-six patients were vaccinated against hepatitis B virus (HBV), of which 29 were female. The average age was 46.2 years. Regarding the type of IBD, twenty-four patients had Crohn's disease and the duration of inflammatory bowel disease was 74 months. Fifteen patients were on concomitant immunosuppressive therapy. The effective response rate to HBV vaccine was 72.2%, verified by anti-HBs titration ≥10 UI/L. Statistical analysis revealed a negative response to vaccination in patients with Crohn's disease and immunosuppressive drugs. The...Continue Reading

References

Aug 23, 1984·The New England Journal of Medicine·C E StevensW Szmuness
Oct 9, 2004·Inflammatory Bowel Diseases·Bruce E SandsWalter Orenstein
Jul 5, 2006·The American Journal of Gastroenterology·Gil Y MelmedEric A Vasiliauskas
May 29, 2008·World Journal of Gastroenterology : WJG·Yolanda Faia Manhaes TolentinoHenrique Sergio Moraes Coelho
Dec 23, 2008·The American Journal of Gastroenterology·Carme LorasUNKNOWN GETECCu (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa)
Mar 10, 2009·Medicina clínica·Luis Vida PérezJuan Francisco De Dios Vega
Aug 5, 2009·Inflammatory Bowel Diseases·Charles N BernsteinGillian Watermeyer
Nov 4, 2009·Inflammatory Bowel Diseases·Jean-Baptiste ChevauxLaurent Peyrin-Biroulet
May 19, 2010·Inflammatory Bowel Diseases·Jason K HouUma Mahadevan
Dec 8, 2011·Digestive Diseases and Sciences·Mustafa Erhan AltunözAyşe Oya Kurdaş Ovünç
May 20, 2014·Canadian Journal of Gastroenterology & Hepatology·Geoffrey C NguyenJennifer Jones
Jun 11, 2014·Best Practice & Research. Clinical Gastroenterology·F Magro, C Abreu
Nov 15, 2017·Primary Care·Tomoko SairenjiDavid V Evans
Aug 29, 2019·Arquivos De Gastroenterologia·Karin Lye Auf der StrasseHeda Maria Barska Dos Santos Amarante

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.